輸入代號或公司名稱後按 Enter
3205

佰研

-0.75 (-1.58%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
46.6038成交張數本益比3.14股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.03-0.12-0.02-0.9%-0.16%-1.60%
2026Q10.05-0.390.032.3%0.32%-4.31%
2025Q4-0.15-0.92-0.11-28.7%-1.08%-6.83%
2025Q30.01-1.02-0.07-7.3%-0.64%-6.12%
2025Q2-0.30-1.48-0.16-14.0%-2.16%-6.93%
2025Q1-0.48-1.68-0.16-15.5%-3.86%-12.21%
2024Q4-0.25-1.49-0.08-6.9%-1.87%-10.52%
2024Q3-0.45-1.81-0.15-12.8%-3.02%-12.64%
2024Q2-0.50-1.70-0.16-13.8%-3.26%-11.82%
2024Q1-0.29-1.55-0.09-8.0%-1.85%-10.93%
2023Q4-0.57-1.69-0.19-17.6%-3.77%-11.51%
2023Q3-0.34-1.69-0.11-10.3%-2.44%-11.85%
2023Q2-0.35-1.67-0.11-10.0%-2.69%-12.13%
2023Q1-0.43-2.06-0.14-12.2%-3.22%-14.47%
2022Q4-0.57-2.28-0.19-14.9%-4.13%-15.48%
2022Q3-0.32-2.40-0.11-7.8%-2.27%-15.99%
2022Q2-0.74-2.81-0.24-17.7%-4.91%-17.88%
2022Q1-0.65-2.63-0.21-15.9%-4.20%-16.14%
2021Q4-0.69-2.66-0.22-15.9%-4.31%-15.67%
2021Q3-0.73-2.56-0.24-16.1%-4.42%-14.82%
2021Q2-0.56-2.47-0.18-11.9%-3.31%-13.73%
2021Q1-0.68-2.64-0.22-15.0%-3.85%-14.02%
2020Q4-0.59-2.27-0.19-13.3%-3.25%-11.76%
2020Q3-0.64-3.04-0.21-16.2%-3.38%-14.96%
2020Q2-0.73-3.25-0.24-17.4%-3.65%-15.38%
2020Q1-0.31-3.14-0.10-6.9%-1.54%-14.37%
2019Q4-1.36-3.65-0.44-41.2%-6.36%-16.24%
2019Q3-0.85-3.44-0.28-24.4%-3.79%-14.29%
2019Q2-0.62-788.9%-3.26-0.20-16.9%-2.68%-13.12%
2019Q1-0.82-2.55-0.27-28.0%-3.42%-9.81%
2018Q4-1.15-2.80-0.38-38.6%-4.56%-10.42%
2018Q3-0.67-3.25-0.22-23.2%-2.54%-11.38%
2018Q20.09-3.520.032.8%0.35%-11.95%
2018Q1-1.07-3.93-0.35-32.5%-3.70%-12.18%
2017Q4-1.60-426.5%-3.48-0.53-53.3%-5.31%-10.49%
2017Q3-0.94-844.8%-1.39-0.31-27.2%-2.97%-3.75%
2017Q2-0.32-109.5%-0.32-0.11-9.3%-0.96%-0.68%
2017Q1-0.62-113.2%3.35-0.20-14.8%-1.68%10.30%
2016Q40.498.660.2012.2%1.67%
2016Q30.130.042.0%0.40%